Fulcrum Therapeutics, Inc. (FULC) vs Rocket Pharmaceuticals, Inc. (RCKT)
A side-by-side comparison of Fulcrum Therapeutics, Inc. and Rocket Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FULC
Fulcrum Therapeutics, Inc.
$3.70HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
RCKT
Rocket Pharmaceuticals, Inc.
$2.49HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
Total return — FULC vs RCKT
growth of $100 · dividends reinvested · last 7yFULC -72.5% (-16.8%/yr)RCKT -79.4% (-20.2%/yr)FULC compounded faster over this window
FULC RCKT
FULC vs RCKT: by the numbers
- •FULC is the larger company ($282M vs $271M market cap).
Metrics side by side
Valuation
| Metric | FULC | RCKT |
|---|---|---|
| P/B ratio | 0.91 | 0.74 |
Profitability
| Metric | FULC | RCKT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -27.36% | -4.68% |
| ROIC | -27.62% | -48.92% |
Growth (annualized)
| Metric | FULC | RCKT |
|---|---|---|
| Total return CAGR (5Y) | -31.70% | -38.33% |
Frequently asked
- How have FULC and RCKT total returns compared?
- Over the past 5 years, FULC delivered -31.70% and RCKT delivered -38.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.